Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
VACCINOGEN INC (VGEN)
|
Add to portfolio |
|
|
|
| Price: |
$0.00
| | Metrics |
| OS: |
36.1
|
M
| |
-70
|
% ROE
|
| Market cap: |
|
| |
|
|
|
Net debt:
|
$3.39
|
M
| |
|
|
|
EV:
|
$3.39
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($3.4)
|
B
| |
|
|
|
EBIT
|
($28.6)
|
M
| |
|
|
| EPS |
($0.77)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| Revenues | 7.8 | -3.1 | -1.3 |
| Revenue growth | -352.2% | 139.8% | |
| Cost of goods sold | 7.8 | -38.9 | -22.2 |
| Gross profit | 0.0 | 35.8 | 20.9 |
| Gross margin | 0.0% | -1164.8% | -1631.8% |
| Research and development | 9.1 | 8.7 | 8.1 |
| General and administrative | 5.7 | 10.8 | 3.0 |
| EBITA | -8.1 | -12.7 | -4.4 |
| EBITA margin | -104.8% | 414.4% | 343.0% |
| Amortization of intangibles | 6.7 | 6.7 | 6.7 |
| EBIT | -14.8 | -19.4 | -11.1 |
| EBIT margin | -191.3% | 632.4% | 865.9% |
| Pre-tax income | -8.3 | -24.6 | -12.7 |
| Income taxes | 0.2 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 0.0% |
| Net income | -8.5 | -24.6 | -12.7 |
| Net margin | -110.0% | 799.5% | 990.2% |
| |
| Diluted EPS | ($0.26) | ($0.79) | ($0.64) |
| Shares outstanding (diluted) | 32.8 | 31.1 | 19.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|